Preview

South Russian Journal of Therapeutic Practice

Advanced search

CLINICAL AND FUNCTIONAL FEATURES OF GASTROESOPHAGEAL REIFLUX DISEASE, COMORBID WITH PEPTIC ULCER DISEASE

https://doi.org/10.21886/2712-8156-2020-1-1-78-83

Abstract

Objective: to study the clinical and functional manifestations of various forms of gastroesophageal reflux disease (GERD) with comorbid peptic ulcer of the duodenum (PUD) and gastric ulcer (GU) to clarify the diagnosis and identify targets for pathogenetic therapy at the stage of primary health care.

Materials and methods: 287 patients with GERD, comorbid with uncomplicated ulcer, were examined. Questioning of patients was carried out, An in-depth endoscopic examination (EGDS) was performed in combination with an acid perfusion test (APT) to detect non-erosive reflux disease (NERD) and gastric endoscopic chromoscopy to determine the acid production of the stomach.

Results: in patients with GERD with comorbid PUD, heartburn and acid regurgitation were more often detected in comparison with NERD. According to the results of chromoscopy, hyperand normochlorhydria were characteristic for patients with PUD, hypochlorhydria - for patients with GU. An acute GERD stage and the frequency of positive CBT are associated with an exacerbation of the PUD. There was a direct correlation between the age of patients and the stage of GERD. Moreover, the age and stage of GERD revealed a direct correlation with a positive APT, which reflects a violation of the permeability of mucosae of the esophagus.

Conclusion: in patients with GERD with comorbid PU, patient-oriented diagnosis may consist of endoscopic chromoscopic determination of stomach acid production and endoscopic APT to confirm NERD and identify GERD phenotypes comorbid with acid-dependent diseases in order to determine treatment tactics.

About the Authors

E. V. Gorban
Kuban State Medical University
Russian Federation
Krasnodar



N. V. Korochanskaya
Kuban State Medical University
Russian Federation

Dr. Sci. (Med.)

Krasnodar



V. V. Gorban
Kuban State Medical University
Russian Federation

Dr. Sci. (Med.)

Krasnodar



References

1. Sidhwa F., Moore A., Alligood E., Fisichella P. Diagnosis and treatment of the extraesophageal manifestations of gastroesophageal reflux disease. Ann. Surg. 2017;265(1):63–67. DOI: 10.1097/SLA.0000000000001907

2. Boeckxstaens G., El-Serag H.B., Smout A.J., Kahrilas P.J. Symptomatic reflux disease: the present, the past and the future. Gut. 2014; 63(7):1185-1193. doi: 10.1136/gutjnl-2013-306393

3. Kahrilas P., Yadlapati R., Roman S. Emerging dilemmas in the diagnosis and management of gastroesophageal reflux disease. F1000Res. 2017;6:1748. doi: 10.12688/f1000research.11918.1

4. Bredenoord A.J., Pandolfino J.E., Smout A.J. Gastro-oesophageal reflux disease. Lancet. 2013; 381(9881):1933-42. doi: 10.1016/S0140-6736(12)62171-0

5. Roman S., Keefer L., Imam H., Korrapati P., Mogni B., Eident K. et al. Neurogastroenterol. Motil. 2015; 27(11):1667-74. doi:10.1111/nmo.12666

6. Gyawali C.P., Kahrilas P.J., Savarino E., Zerbib F., Mion F., Smout A.J.P.M. et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018; 67:1351–1362. doi: 10.1136/gutjnl-2017-314722

7. Ye B.X., Jiang L.Q., Lin L. Wang Y., M. Wang M. Reflux episodes and esophageal impedance levels in patients with typical and atypical symptoms of gastroesophageal reflux disease. Medicine. 2017;96(37):e7978. doi: 10.1097/MD.0000000000007978

8. Dent J., El-Serag H.B., Wallander M.A., Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54(5):710-7. doi: 10.1136/gut.2004.051821

9. Nakada K., Matsuhashi N., Iwakiri K., Oshio A., Joh T., Higuchi K. at al. Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms. World J. Gastroenterol. 2017;23(28):5216-5228. DOI: 10.3748/wjg.v23.i28.5216

10. Vakil N., van Zanten S.V., Kahrilas P., Dent J., Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol. 2006;101:1900-1920. DOI: 10.1111/j.1572-0241.2006.00630.x.

11. Fujiwara Y., Higuchi K., Shiba M., Watanabe T., Tominaga K., Oshitani N. et al. Association between gastroesophageal flap valve, reflux esophagitis, Barrett,s epithelium, and atrophic gastritis assessed by endoscopy in Japanese patients. J. Gastroenterol. 2003;38(6):533-39. DOI: 10.1007/s00535-002-1100-9

12. Nobakht H., Boghratian A., Sohrabi M., Panahian M., Rakhshani N., Nikkhah M. Association between Pattern of Gastritis and Gastroesophageal Reflux Disease in Patients with Helicobacter Pylori Infection. Middle East Journal of Digestive Diseases. 2016;8(3):206-211. Doi :10.15171/mejdd.2016.33

13. Badillo R., Francis D. Diagnosis and treatment of gastroesophageal reflux disease. World J. Gastrointest. Pharmacol. Ther. 2014;5(3):105-112. DOI: 10.4292/wjgpt.v5.i3.105

14. Xie C., Li Y., Zhang N., Xiong L., Chen M., Xiao Y. Gastroesophageal flap valve reflected EGJ morphology and correlated to acid reflux. BMC Gastroenterology. 2017;17(1):118. DOI 10.1186/s12876-017-0693-7

15. Weijenborg P.W., Smout A.J., Verseijden C., Verseijden C., van Veen H.A., Verheij J. et al. Hypersensitivity to acid is associated with impaired esophageal mucosal integrity in patients with gastroesophageal reflux disease with and without esophagitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2014;307(3):G323–9. doi: 10.1152/ajpgi.00345.2013

16. Fernandes M.R., De Oliveira M., Callegari-Jacques S.M., Gon-çalves G.V.R., Fornari F. Juice Test for Identification of Nonerosive Reflux Disease in Heartburn Patients. J. Neurogastroenterol. Motil. 2018;24(2):233-240. doi: 10.5056/jnm17077

17. Kahrilas P.J., Keefer L., Pandolfino J.E. Patients with refractory reflux symptoms: What do they have and how should they be managed? Neurogastroenterol. Motil. 2015;27(9):1195–201. doi: 10.1111/nmo.12644

18. Min Y.W., Choi K., Pyo J.H., Son H.J., Rhee P.L. Impaired esophageal mucosal integrity may play a causative role in patients with nongastroesophageal reflux disease-related noncardiac chest pain. Medicine (Baltimore). 2015;94(51):e2295. doi: 10.1097/MD.0000000000002295

19. Farré R., Fornari F., Blondeau K., Vieth M., De Vos R., Bisschops R. Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus. Gut. 2010;59(2):164-9. doi: 10.1136/gut.2009.194191


Review

For citations:


Gorban E.V., Korochanskaya N.V., Gorban V.V. CLINICAL AND FUNCTIONAL FEATURES OF GASTROESOPHAGEAL REIFLUX DISEASE, COMORBID WITH PEPTIC ULCER DISEASE. South Russian Journal of Therapeutic Practice. 2020;1(1):78-83. (In Russ.) https://doi.org/10.21886/2712-8156-2020-1-1-78-83

Views: 768


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2712-8156 (Print)